Table 1 Baseline patients’ characteristics
From: Mitral prosthetic size predictor in minimally invasive mitral valve replacement
Variables | Number (n = 96) |
|---|---|
Age (years), mean ± SD | 54.2 ± 9.5 |
Male, n (%) | 51 (53.1) |
BMI | 21.9 ± 6.8 |
Comorbidities, n (%) | |
+ Hypertension, n (%) | 42 (43.8) |
+ Type II diabetes mellitus, n (%) | 27 (28.1) |
+ Preoperative atrial fibrillation, n (%) | 31 (32.3) |
Etiology | |
+ Post rheumatic, n (%) | 39 (40.6) |
+ Degenerative, n (%) | 57 (59.4) |
TTE characteristics | |
Mean ejection fraction (EF, %) | 58.4 ± 11.2 |
Mitral regurigation | 57 |
Mitral stenosis | 23 |
Mitral stenosis and regurgitation | 16 |
NYHA classifications | |
+ NYHA I, n (%) | 7 (7.3) |
+ NYHA II, n (%) | 79 (82.3) |
+ NYHA III, n (%) | 9 (9.4) |
+ NYHA IV, n (%) | 1 (1) |
Types of prosthesis | |
+ Mechanical valve, n (%) | 46 (47.9) |
+ Tissue valve n (%) | 50 (52.1) |
Valve size (mm), mean ± SD | 26.78 ± 3.36 |
+ Mechanical valve | 26.91 ± 3.4 |
+ Tissue valve | 26.67 ± 3.26 |
Posterior leaflet preservation, n (%) | 94 (97.9%) |